Lupin Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid".
Lupin Limited has informed the Exchange regarding a press release dated May 05, 2026, titled "Lupin Receives U.S. FDA Approval for Glycerol Phenylbutyrate Oral Liquid".